Literature DB >> 3878752

Functional consequences of perceived interleukin deficiencies? Analysis employing NZB x C58 recombinant inbred mice.

M H Bocchieri, J B Smith, J B Smith, M J Staruch, D D Wood.   

Abstract

NZB mice have previously been shown to be deficient in the production of interleukins 1 and 2 (IL-1, IL-2) during the development of autoimmune disease. One or both of these defects have been inherited in certain of the NZB X C58 recombinant inbred strains (N X 8 RI). Certain of these strains have been selected to examine further the effect of decreased production of IL-1 and/or IL-2. The interleukin deficiencies found in vitro were not due to the presence of an inhibitor/suppressor nor was any activity found intracellularly upon water lysis of stimulated cells. Despite profound IL-1 and/or IL-2 deficiencies measured in vitro, all of the N X 8 RI lines examined were found to be capable of producing IL-1 in vivo as shown by their serum amyloid A response to endotoxin injection. We conclude from these studies that defects in IL-1 production measured in vitro do not reflect inability to produce this lymphokine in vivo. Young, IL-1 deficient NZB mice generated CTL to TNP-self but old, IL-2 deficient NZB mice did not. Since all other strains were found to generate cytotoxic T cells to TNP-self regardless of interleukin defects, we also conclude that the cytotoxic T cell defect in NZB mice is due to some presently unknown factor in addition to IL-2 deficiency. The relationship of decreased production of interleukins to the development of autoimmunity remains undefined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878752      PMCID: PMC1577467     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.

Authors:  S Izui; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

Review 3.  Histocompatibility systems, immune response, and disease in man.

Authors:  P J Morris
Journal:  Contemp Top Immunobiol       Date:  1974

4.  Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.

Authors:  J A Wolos; J B Smith
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

Review 5.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Physicochemical characterization of lymphocyte-activating factor (LAF).

Authors:  S B Mizel
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

7.  Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice.

Authors:  J B Smith; R D Pasternak
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

8.  Cytokine production by NZB, C58, and NZB X C58 recombinant inbred mice.

Authors:  M H Bocchieri; L Knittweis; D S Seaton
Journal:  Cell Immunol       Date:  1984-10-15       Impact factor: 4.868

9.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  T cell abnormalities in NZB mice occur independently of autoantibody production.

Authors:  J D Taurog; E S Raveche; P A Smathers; L H Glimcher; D P Huston; C T Hansen; A D Steinberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  2 in total

1.  Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors.

Authors:  J B Smith; M H Bocchieri; L Sherbin-Allen; M Borofsky; J L Abruzzo
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Abnormal T-cell function in patients with psoriatic arthritis: evidence for decreased interleukin 2 production.

Authors:  J G Fort; J B Smith; J L Abruzzo
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.